TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 108 filers reported holding TRICIDA INC in Q1 2021. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $163 | -100.0% | 1,067,010 | +1469.1% | 0.00% | – |
Q3 2022 | $713,000 | -66.6% | 68,000 | -69.2% | 0.00% | -100.0% |
Q2 2022 | $2,135,000 | -48.3% | 220,548 | -56.1% | 0.00% | -50.0% |
Q1 2022 | $4,132,000 | +243.2% | 502,713 | +299.2% | 0.00% | +100.0% |
Q4 2021 | $1,204,000 | +18.5% | 125,930 | -42.5% | 0.00% | 0.0% |
Q3 2021 | $1,016,000 | -45.7% | 218,906 | -49.4% | 0.00% | 0.0% |
Q2 2021 | $1,870,000 | -63.1% | 432,949 | -39.8% | 0.00% | -75.0% |
Q4 2020 | $5,070,000 | +433.7% | 719,195 | +586.1% | 0.00% | +300.0% |
Q3 2020 | $950,000 | -88.9% | 104,823 | -66.4% | 0.00% | -91.7% |
Q2 2020 | $8,586,000 | +356.2% | 312,428 | +265.1% | 0.01% | +200.0% |
Q1 2020 | $1,882,000 | -55.9% | 85,563 | -24.3% | 0.00% | -20.0% |
Q4 2019 | $4,268,000 | +305.3% | 113,094 | +231.5% | 0.01% | +150.0% |
Q3 2019 | $1,053,000 | -72.5% | 34,115 | -64.8% | 0.00% | -66.7% |
Q2 2019 | $3,823,000 | +148.6% | 96,893 | +92.5% | 0.01% | +200.0% |
Q3 2018 | $1,538,000 | -82.5% | 50,335 | -82.8% | 0.00% | -81.8% |
Q2 2018 | $8,766,000 | – | 293,186 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |